Kiang TK, MH E. Anti-rejection drugs. In: Murphy JE, editor. Clinical pharmacokinetics, 6th edn. American Society of Health-System Pharmacists; 2017.

Kiang, TK, MH E. Immunosuppressants. In: Beringer PE, editor. Basic clinical pharmacokinetics, 6th edn. Wolters Kluwer; 2017.

Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, et al. Personalized therapy for mycophenolate: consensus report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology. Ther Drug Monit. 2021;43(2):150–200. https://doi.org/10.1097/FTD.0000000000000871.

Article  CAS  PubMed  Google Scholar 

Rong Y, Patel V, Kiang TKL. Recent lessons learned from population pharmacokinetic studies of mycophenolic acid: physiological, genomic, and drug interactions leading to the prediction of drug effects. Expert Opin Drug Metab Toxicol. 2021;17(12):1369–406. https://doi.org/10.1080/17425255.2021.2027906.

Article  PubMed  Google Scholar 

Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet. 2007;46(1):13–58. https://doi.org/10.2165/00003088-200746010-00002.

Article  CAS  PubMed  Google Scholar 

Staatz CE, Tett SE. Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update. Arch Toxicol. 2014;88(7):1351–89. https://doi.org/10.1007/s00204-014-1247-1.

Article  CAS  PubMed  Google Scholar 

Picard N, Ratanasavanh D, Prémaud A, Le Meur Y, Marquet P. Identification of the UDP-glucuronosyltransferase isoforms involved in mycophenolic acid phase II metabolism. Drug Metab Dispos. 2005;33(1):139–46. https://doi.org/10.1124/dmd.104.001651.

Article  CAS  PubMed  Google Scholar 

Sherwin CM, Fukuda T, Brunner HI, Goebel J, Vinks AA. The evolution of population pharmacokinetic models to describe the enterohepatic recycling of mycophenolic acid in solid organ transplantation and autoimmune disease. Clin Pharmacokinet. 2011;50(1):1–24. https://doi.org/10.2165/11536640-000000000-00000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998;34(6):429–55. https://doi.org/10.2165/00003088-199834060-00002.

Article  CAS  PubMed  Google Scholar 

Lamba V, Sangkuhl K, Sanghavi K, Fish A, Altman RB, Klein TE. PharmGKB summary: mycophenolic acid pathway. Pharmacogenet Genomics. 2014;24(1):73–9. https://doi.org/10.1097/fpc.0000000000000010.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kiang TKL, Ensom MHH. Population pharmacokinetics of mycophenolic acid: an update. Clin Pharmacokinet. 2018;57(5):547–58. https://doi.org/10.1007/s40262-017-0593-6.

Article  CAS  PubMed  Google Scholar 

Rong Y, Jun H, Kiang TKL. Population pharmacokinetics of mycophenolic acid in paediatric patients. Br J Clin Pharmacol. 2021;87(4):1730–57. https://doi.org/10.1111/bcp.14590.

Article  CAS  PubMed  Google Scholar 

Metz DK, Holford N, Kausman JY, Walker A, Cranswick N, Staatz CE, et al. Optimizing mycophenolic acid exposure in kidney transplant recipients: time for target concentration intervention. Transplantation. 2019. https://doi.org/10.1097/TP.0000000000002762.

Article  PubMed  PubMed Central  Google Scholar 

Kuypers DR, de Jonge H, Naesens M, de Loor H, Halewijck E, Dekens M, et al. Current target ranges of mycophenolic acid exposure and drug-related adverse events: a 5-year, open-label, prospective, clinical follow-up study in renal allograft recipients. Clin Ther. 2008;30(4):673–83. https://doi.org/10.1016/j.clinthera.2008.04.014.

Article  CAS  PubMed  Google Scholar 

Kiang TKL, Ensom MHH. Exposure-toxicity relationships of mycophenolic acid in adult kidney transplant patients. Clin Pharmacokinet. 2019;58(12):1533–52. https://doi.org/10.1007/s40262-019-00802-z.

Article  CAS  PubMed  Google Scholar 

Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. p-Cresyl sulfate. Toxins (Basel). 2017. https://doi.org/10.3390/toxins9020052.

Article  PubMed  PubMed Central  Google Scholar 

Leong SC, Sirich TL. Indoxyl sulfate-review of toxicity and therapeutic strategies. Toxins (Basel). 2016. https://doi.org/10.3390/toxins8120358.

Article  PubMed  PubMed Central  Google Scholar 

Vanholder R, Pletinck A, Schepers E, Glorieux G. Biochemical and clinical impact of organic uremic retention solutes: a comprehensive update. Toxins (Basel). 2018. https://doi.org/10.3390/toxins10010033.

Article  PubMed  PubMed Central  Google Scholar 

Al-Dajani AR, Hou QK, Kiang TKL. Liquid chromatography–mass spectrometry analytical methods for the quantitation of p-cresol sulfate and indoxyl sulfate in human matrices: biological applications and diagnostic potentials. Pharmaceutics. 2024;16(6):743. https://doi.org/10.3390/pharmaceutics16060743.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boelaert J, Lynen F, Glorieux G, Eloot S, Van Landschoot M, Waterloos MA, et al. A novel UPLC–MS–MS method for simultaneous determination of seven uremic retention toxins with cardiovascular relevance in chronic kidney disease patients. Anal Bioanal Chem. 2013;405(6):1937–47. https://doi.org/10.1007/s00216-012-6636-9.

Article  CAS  PubMed  Google Scholar 

Lin CN, Wu IW, Huang YF, Peng SY, Huang YC, Ning HC. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC–MS/MS. J Food Drug Anal. 2019;27(2):502–9. https://doi.org/10.1016/j.jfda.2018.10.008.

Article  CAS  PubMed  Google Scholar 

Glorieux G, Vanholder R, Van Biesen W, Pletinck A, Schepers E, Neirynck N, et al. Free p-cresyl sulfate shows the highest association with cardiovascular outcome in chronic kidney disease. Nephrol Dial Transplant. 2021;36(6):998–1005. https://doi.org/10.1093/ndt/gfab004.

Article  CAS  PubMed  Google Scholar 

Wu IW, Hsu KH, Hsu HJ, Lee CC, Sun CY, Tsai CJ, et al. Serum free p-cresyl sulfate levels predict cardiovascular and all-cause mortality in elderly hemodialysis patients—a prospective cohort study. Nephrol Dial Transplant. 2012;27(3):1169–75. https://doi.org/10.1093/ndt/gfr453.

Article  CAS  PubMed  Google Scholar 

Renaldi R, Wiguna T, Persico AM, Tanra AJ. p-Cresol and p-cresyl sulphate boost oxidative stress: a systematic review of recent evidence. Basic Clin Pharmacol Toxicol. 2025;137(1):e70065. https://doi.org/10.1111/bcpt.70065.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Poveda J, Sanchez-Niño MD, Glorieux G, Sanz AB, Egido J, Vanholder R, et al. p-Cresyl sulphate has pro-inflammatory and cytotoxic actions on human proximal tubular epithelial cells. Nephrol Dial Transplant. 2014;29(1):56–64. https://doi.org/10.1093/ndt/gft367.

Article  CAS  PubMed  Google Scholar 

Barnes KJ, Rowland A, Polasek TM, Miners JO. Inhibition of human drug-metabolising cytochrome P450 and UDP-glucuronosyltransferase enzyme activities in vitro by uremic toxins. Eur J Clin Pharmacol. 2014;70(9):1097–106. https://doi.org/10.1007/s00228-014-1709-7.

Article  CAS  PubMed  Google Scholar 

Rong Y, Kiang TKL. Development and validation of a sensitive liquid-chromatography tandem mass spectrometry assay for mycophenolic acid and metabolites in HepaRG cell culture: characterization of metabolism interactions between p-cresol and mycophenolic acid. Biomed Chromatogr. 2019;33(8):e4549. https://doi.org/10.1002/bmc.4549.

Article  CAS  PubMed  Google Scholar 

Rong Y, Kiang TKL. Mechanisms of metabolism interaction between p-cresol and mycophenolic acid. Toxicol Sci. 2020;173(2):267–79. https://doi.org/10.1093/toxsci/kfz231.

Article  CAS  PubMed  Google Scholar 

Poesen R, Evenepoel P, de Loor H, Bammens B, Claes K, Sprangers B, et al. The influence of renal transplantation on retained microbial-human co-metabolites. Nephrol Dial Transplant. 2016;31(10):1721–9. https://doi.org/10.1093/ndt/gfw009.